McKee A, Peyerl F. TSI assay utilization: impact on costs of Graves’ hyperthyroidism diagnosis. Am J Manag Care. 2012;18(1):e1-14. View article
Tag: Chronic disease
Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment
Joy MS, Karagiannis PC, Peyerl FW. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. J Manag Care Pharm. 2007;13(5):397-411. doi:10.18553/jmcp.2007.13.5.397. View Article